Trial Profile
A trial investigating interactions between almorexant and desipramine in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Almorexant (Primary) ; Desipramine (Primary)
- Indications Attention-deficit hyperactivity disorder; Insomnia; Major depressive disorder; Neuropathic pain
- Focus Pharmacodynamics; Pharmacokinetics
- 05 Nov 2010 New trial record.